Navigation Links
Developers: Deadline Approaching for Allscripts Million Hearts CDS Challenge
Date:6/25/2012

CHICAGO, June 25, 2012 /PRNewswire/ -- To help providers deliver the best possible care to patients with cardiovascular diseases, Allscripts is sponsoring the Allscripts Million Hearts Clinical Decision Support (CDS) Challenge. The challenge, which was announced in January, offers a $50,000 prize to the person or group that creates a publicly available application that accelerates the delivery of optimal care for patients with cardiovascular disease through clinical decision support functionality.  The deadline for submissions by interested parties is July 13, 2012.

Million Hearts is a national initiative announced last year by the U.S. Department of Health & Human Services to prevent 1 million heart attacks and strokes over the next five years. The Allscripts prize will go to the person or group that best translates the rules associated with the Million Hearts initiative into a clear, clinical decision support application that can be read by any Electronic Health Record. Allscripts is providing an XML format that participants may use and extend.  

"An estimated 80 million Americans have one or more types of cardiovascular disease, and they cost Americans approximately $400 billion in direct and indirect healthcare and related costs each year," said Doug Gentile, Chief Medical Officer of Allscripts. "Health information technology can play an important role in combating these diseases by informing healthcare providers more effectively during the care process, and through the Million Hearts Clinical Decision Support Challenge, Allscripts hopes to inspire developers to help us in our mission to enable better quality outcomes for heart patients nationwide."

"The importance of this challenge is that it's focused on having the community –  physicians, nurses, and other caregivers – create an application that could be available on any EHR that is open and easy to access," said Glen Tullman, Chief Executive Officer of Allscripts. "As health care becomes an information-driven business, leveraging the intelligence of the community will help improve patient care."

Learn more about the challenge here or go to http://www.allscripts.com/cdschallenge.  Entries are due by July 13, 2012. Allscripts will announce the winning entry no later than September 30, 2012.

Participation in the Allscripts Million Hearts CDS Challenge, including the use of Allscripts XML format, is subject to the terms and conditions available at http://www.allscripts.com/en/company/about-us/in-the-community/cdschallenge/CDS-rules.html.

About Allscripts
Allscripts (NASDAQ:  MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations.  To learn more about Allscripts, please visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that the expected synergies, efficiencies and cost savings of the merger with Eclipsys Corporation ("Eclipsys") will not be realized, or will not be realized within the expected time period; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that the Allscripts and Eclipsys businesses will not be integrated successfully; competition within the industries in which we operate; failure to achieve certification under the Health Information Technology for Economic and Clinical Health Act could result in increased development costs, a breach of some customer obligations and could put us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; the outcome of any legal proceeding that has been or may be instituted against us; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; and breach of our security by third parties. See our Annual Report on Form 10-K for 2011 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.

(Logo: http://photos.prnewswire.com/prnh/20100901/CG58147LOGO)


'/>"/>
SOURCE Allscripts Healthcare Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
2. Allscripts Adds Two Independent Directors to Board
3. Biodel Announces $18.5 Million Private Placement
4. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
5. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
6. Millions Around the World to Have Access to Low-Cost HIV Test by 2013
7. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
8. Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research
9. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
10. Igenica Closes $33 Million in Series C Funding
11. C8 MediSensors Closes $19 million Preferred Stock Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):